Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mebeverine in children with irritable bowel syndrome or functional abdominal pain
2015-003293-32Phase 4Active
- Sponsor
- Academic Medical Center
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in irritable bowel syndrome (IBS) and functional abdominal pain syndrome (CAPS) comparing Mebeverine with Placebo (2 arms). Primary endpoint: Responder rate for abdominal pain improvement after 8 weeks. Started Dec 2015; status: active.
02
Drugs
mebeverine
03
Conditions
irritable bowel syndrome (IBS)functional abdominal pain syndrome (CAPS)
Beyond the preview
Go deeper on 2015-003293-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003293-32.